-
Semax 20 mg
Hailing from Russia, Semax has demonstrated its efficacy
in diverse scenarios such as stroke, cognitive impairment,
dementia, and inflammation of the optic nerve. Beyond
these applications, it has undergone evaluation as a
prospective immune system enhancer and exhibited
antidepressant and anxiolytic properties. Studies have
highlighted Semax’s capability to elevate levels of brainderived neurotrophic factor (BDNF) within the central
nervous system, along with increased levels of serotonin
and dopamine. -
-
Tesamorelin 5mg
Tesamorelin, an analogue of growth hormone releasing
hormone (GHRH), mirrors the structure of standard GHRH,
enhanced by the addition of an extra trans-3-hexanoic acid
group. Developed by Theratechnologies in Canada,
Tesamorelin earned FDA approval in 2010 as the latest
drug for managing HIV-associated lipodystrophy. Beyond
its approved use, the peptide has undergone exploration
regarding its potential to enhance peripheral nerve
regeneration and as a potential intervention for mild
cognitive impairment (MCI), which precedes dementia. -
Thymulin 20 mg
Thymalin, a synthetic iteration of thymulin discovered in
1977 within the thymus, has exhibited multiple roles,
including regulation of inflammation and pain, fostering
neuroprotective effects, and playing a significant part in
immune functionality. Initial investigations also indicated
that thymalin, along with extracts from the thymus and
pineal gland, might contribute to prolonging life. -
Tirzepatide 5mg
Tirzepatide was initially designed to combat type 2 diabetes, but it has demonstrated additional benefits in safeguarding the cardiovascular system and serving as a robust weight loss agent. As a synthetic derivative of gastric inhibitory polypeptide (GIP), Tirzepatide uniquely combines glucagon-like peptide-1 (GLP-1) functionality. This dual action empowers Tirzepatide to effectively lower blood glucose levels, enhance insulin sensitivity, promote feelings of satiety, and expedite weight loss.
-